Posted on Leave a comment

US Single-use Assemblies Market worth US$1658.8 million by 2029 with 15.0% CAGR

US plasma fractionation market is segmented into pulmonology, hemato-oncology neurology, immunology, hematology, critical care, rheumatology, and other applications. Key players in the US plasma fractionation market include ADMA Biologics (US), and Emergent BioSolutions (US). The global US Single-use Assemblies Market is expected to reach US$1658.8 billion by 2029 from US$825.1 billion in 2024, at a […]

Posted on Leave a comment

Carcinoid Tumor Syndrome Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight

DelveInsight “Carcinoid Tumor Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Carcinoid Tumor Syndrome, historical and forecasted epidemiology as well as the Carcinoid Tumor Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover which therapies are expected to grab the […]

Posted on Leave a comment

Amblyopia Market Set for Growth: Technological Advancements and Early Detection Drive Expansion in 7MM | DelveInsight

The Amblyopia comapnies in the market include – Novartis AG, NovaSight, Bausch + Lomb Incorporated, Vivid Vision Inc., RevitalVision, Hilco Vision, Bynocs, Eyenovia Inc., Adaptica Srl, AmblyoPlay, Oculus Pharmaceuticals Ltd., CooperVision, Fresnel Prism and Lens Co., HOYA Vision Care, Luminopia, and others.   The amblyopia market is witnessing significant growth in 7MM, driven by increasing […]

Posted on Leave a comment

Ulcerative Colitis Market Set for Robust Growth Across the 7MM from USD 8.4 Billion in 2023 | DelveInsight

Key Ulcerative Colitis companies in the market include – Arena Pharmaceuticals, Pfizer, Abivax, Reistone Biopharma, InDex Pharmaceuticals, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Landos Biopharma, NImmune, Merck and Mesoblast, among others. The Ulcerative Colitis treatment paradigm is undergoing a dynamic evolution, marked by increasing therapeutic interventions by companies such as Arena Pharmaceuticals, Pfizer, Abivax, Reistone Biopharma, […]

Posted on Leave a comment

Vernal Keratoconjunctivitis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Vernal Keratoconjunctivitis Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Vernal Keratoconjunctivitis pipeline landscape. It covers the Vernal Keratoconjunctivitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Vernal Keratoconjunctivitis therapeutics assessment by product type, stage, route of administration, and molecule type. It […]

Posted on Leave a comment

Nonmelanoma Skin Cancer Market Poised for Significant Growth by 2034 as Novel Therapies Emerge | DelveInsight

The Nonmelanoma Skin Cancer companies in the market include – Sensus Healthcare, DUSA Pharmaceuticals Inc., Skin Analytics Limited, Pfizer, Bristol-Myers Squibb, Sirnaomics, AiViva BioPharma, and Exicure, among others.   The Nonmelanoma Skin Cancer market is expected to experience substantial growth from 2024 to 2034, driven by increasing disease prevalence, advancements in diagnostic techniques, and the […]

Posted on Leave a comment

What form of vitamin A is best absorbed

Understanding Vitamin A Vitamin A comes in two main forms: Pre-retinoic acid (found in animal foods) and carotenoids (extracted from plants). Pre-retinoids such as retinol, retinaldehyde, and retinoic acid are directly utilized by the body. Retinol is the most common form found in dietary supplements and animal products (such as liver, fish oil, and dairy […]

Posted on Leave a comment

Post Bariatric Hypoglycemia Market Set to Grow Substantially Through 2034, DelveInsight Projects | RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc.

The Key Post Bariatric Hypoglycemia Companies in the market include – RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc., and others.   DelveInsight’s “Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Post Bariatric Hypoglycemia, historical and forecasted epidemiology as well as the Post Bariatric Hypoglycemia […]

Posted on Leave a comment

Hypertension Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Hypertension Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products […]

Posted on Leave a comment

EGFR Non Small Cell Lung Cancer Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Bridge Biotherapeutics, Inc., Sichuan Kelun Pharmaceutical

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ EGFR Non Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   The EGFR Non Small Cell […]